研究表明 糖尿病致中國成年患者減壽9年

People in China diagnosed with diabetes in middle age lost an average nine years of life, according to a new study published in the Journal of the American Medical Association.

根據發表在《美國醫學會雜誌》上的一項新研究，中年時確診患有糖尿病的中國人的壽命平均短了9年。

Researchers from the University of Oxford and Peking University examined the association of diabetes with mortality in 500,000 adults from 10 areas across China, including five from rural areas and five from urban.

牛津大學和北京大學的研究人員調查了糖尿病與死亡率之間的聯繫，研究對象爲我國10個地區(包括5個農村地區和5個城市地區)的50萬名成年人。

The study showed that diabetes raised the risk of dying from a wide range of conditions, including heart disease, stroke, kidney disease, liver disease, infection, and cancers of the liver, pancreas and breast.

研究顯示，糖尿病增加了心臟病、中風、腎病、肝病、感染以及肝癌、胰腺癌和乳癌等多種疾病的死亡風險。

The researchers also estimated that the 25-year probability of death would be 69% among those diagnosed with diabetes at age 50 compared with 38% among otherwise similar individuals without diabetes, corresponding to a loss of about nine years of life - 10 years in rural areas and eight years in urban areas.

研究人員還估算，在其餘條件相近的情況下，50歲時確診患有糖尿病的人隨後25年的死亡概率爲69%，無糖尿病者的死亡概率爲38%，相當於"減壽"約9年——農村地區爲10年，城市地區爲8年。

"As the prevalence of diabetes in young adults increases and the adult population grows, the annual number of deaths related to diabetes is likely to continue to increase, unless there is substantial improvement in prevention and management," the researchers wrote.

研究人員寫道：“隨着年輕人糖尿病患病率的增加以及成年人口的增長，除非在預防和管理方面有實質性的改進，否則與糖尿病相關的年死亡人數有可能會繼續增加。”

Margaret Chan, director-general of the World Health Organization (WHO), described in an accompanying editorial this study as "the first reliable evidence of the specific diseases and complications that account for mortality among Chinese individuals with diabetes."

世界衛生組織總幹事陳馮富珍，在一篇社論中描述這項研究爲：“中國糖尿病患者特定疾病與併發症死亡原因的第一個可靠證據。”

"The quality of precise measurement reported by the study provides confidence that Chinese authorities will continue to move the country's health reforms in the right direction, with results that also improve the prevention and control of diabetes," she said.

她說道：“此項研究所得出的高質量和精準的風險評估，使我們確信，中國政府將會繼續朝着正確的方向推進醫療改革，其結果將會改善糖尿病的預防與控制。”